We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Lollipop-Based Saliva Collection System Could Become New Gold Standard for Disease Diagnostics

By LabMedica International staff writers
Posted on 12 Jul 2023

Throat swabs are routinely used to obtain samples for the diagnosis of a wide variety of disorders, including strep throat. More...

Saliva sampling, in which technicians analyze a patient’s spit using methods such as quantitative polymerase chain reaction (qPCR), is a less-gag-inducing procedure. This approach is useful for at-home testing and saw greater use during the COVID-19 epidemic as this type of sample can be taken directly by a patient. However, collecting the required amount of saliva can be quite a distasteful experience. As a result, some scientists are aiming to make the process more delightful by mixing it with the equally drool-filled, though far more pleasant, experience of eating a lollipop.

Researchers at University of Washington (Seattle, WA, USA) have demonstrated for the first time that a lollipop-based saliva collection system is capable of capturing bacteria from adults and can remain shelf-stable for almost a year. CandyCollect, the lollipop collection device previously developed by the researchers, appears similar to a lollipop but features a spoon-like stick with a spiral-shaped groove carved into the top. This flattened end covered with isomalt candy enables saliva to easily flow into the groove as the lollipop is eaten. In an earlier study, the researchers had conducted lab tests that demonstrated CandyCollect was capable of capturing the bacteria causing strep throat. This time, the team focused on other naturally occurring bacteria and compared how CandyCollect performed among real people relative to other at-home saliva sampling methods available in the market.

The study involved 28 adult volunteers who received CandyCollect along with two conventional saliva sampling kits. After using them, the participants sent the devices back to the lab along with answers to specific survey questions. The research team eluted the samples and then quantified Streptococcus mutans and Staphylococcus aureus bacteria employing qPCR. They found that every time one or both of the conventional methods detected the target bacteria, CandyCollect was also successful in detecting them each time. The study participants also showed a greater preference for candies over conventional collection systems. CandyCollect was the most popular method out of the three devices among the volunteers who agreed that it was the “most sanitary” and “least disgusting.” Additionally, CandyCollect generated accurate results after being stored for a year. The findings suggest that CandyCollect is adaptable and preferred, but will continue to undergo further studies and could encourage others to design similar intuitive and easy-to-use at-home testing methods.

Related Links:
University of Washington 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.